Prof. MD. Taner Şeker

Education and Specialization

• 2002–2008 Çukurova University Faculty of Medicine, M.D.
• 2009–2013 Adana Numune Training and Research Hospital, Cardiologist

Experience

• 2008–2009 Erzurum Karayazı Göksu Health Center
• 2009 - 2013 Adana Numune and Research Hospital, Cardiology Clinic
• 2013 - 2016 Adana Numune and Research Hospital, Cardiology Clinic
• 2016 - 2018 Osmaniye State Hospital
• 2018 - Adana Training and Research Hospital Cardiology Clinic
• 2019 - 2023 Adana City Hospital 
• 2023 - Medical Park Adana Hospital 

Courses and Certifications

• Turkish Society of Cardiology Certification, Turkish Society of Cardiology Certification
  
• The Society for Cardiovascular Angiography and Interventions, Adult Interventional Cardiology Fellows Course, Las Vegas
  
• Rotterdam Preceptorship—Angiography Is Not Enough, IVUS-iFFR-FFR Course at Erasmus
• MC Thorax Centre Rotterdam, The Netherlands, Erasmus MC Thorax Centre Rotterdam, Rotterdam
  
• Peripheral Intervention Course, TKD Interventional - 2nd Peripheral Intervention Course, Pendik, Pendik/Istanbul,
  
• AKEDEMIKA - Good Clinical Practice (GCP), Successful completion of the AKEDEMIKA Program on the Principles of Proper Practice in Clinical Research held November 13–15, 2009. This program has been accredited by the European Council for Accreditation of Continuing Medical Education (ECMEC), an institution of the European Union of Medical Specialists, and is eligible for 10 European CME credits or 10 ECMEC credit points.,
• Istanbul, Course, November 13, 2009 – November 15, 2009 (National)
• Coronary Bifurcation Stenting Technique, Temporary Stenting
• What Are the Key Considerations in Bifurcation Stenting Strategy? TAP, DKK.

Professional Memberships

• 2014 Society for Cardiovascular Angiography and Interventions (SCAI), Member
  
• 2013 Turkish Society of Cardiology, Member
  
• 2013 European Society of Cardiology Member

Foreign Language

• English

International Peer-Reviewed Journal Articles (A)

A1. Şeker T, Türkoğlu C, Harbalıoğlu H, Gür M. Epicardial Fat Thickness is Associated with Abnormal Left Ventricle Geometry in Newly Diagnosed Hypertension. Acta Cardiologica Sinica. 2018;34(3):280-287. doi:10.6515/ACS.201805_34(3).20171209A

A2. Şeker T, Türkoğlu C, Harbalıoğlu H, Gür M. The impact of diabetes on the association between epicardial fat thickness and the extent and complexity of coronary artery disease in patients with non-ST elevation myocardial infarction. Kardiologia Polska. 2017;75(11):1177-1184. doi:10.5603/KP.a2017.0139

A3. Kaypaklı O, Gür M, Harbalıoğlu H, Şeker T, Selek Ş. High morning blood pressure surge is associated with oxidative stress and paraoxonase-1 activity in newly diagnosed hypertensive patients. Clinical and Experimental Hypertension. 2016;38(8):680-685. doi:10.1080/10641963.2016.1200602

A4. Türkoğlu C, Gür M, Şeker T, Selek Ş, Koçyiğit A. The predictive value of M30 and oxidative stress for left ventricular remodeling in anterior STEMI treated with primary PCI. Coronary Artery Disease. 2016;27(8):690-695. doi:10.1097/MCA.0000000000000416

A5. Şeker T, Gür M, Yüksel Kalkan G, et al. Serum 25-Hydroxyvitamin D Level and Extent and Complexity of Coronary Artery Disease. Journal of Clinical Laboratory Analysis. 2014;28(1):52-58. doi:10.1002/jcla.21643

A6. Şeker T, Acele A, Topuz M, Çölkesen A Y. Delayed Displacement of Aortic Coarctation Stent. JACC: Cardiovascular Interventions. 2016;9(11):103-104. doi:10.1016/j.jcin.2016.02.017

A7. Şeker T, Harbalıoğlu H, Gür M, Çaylı M. Successful treatment of totally occluded innominate artery in subclavian steal syndrome. The Anatolian Journal of Cardiology. 2016;16(4):296-297. doi:10.14744/AnatolJCardiol.2016.7008

A8. Şeker T, Gür M, Kuloğlu O, et al. Serum 25-hydroxyvitamin D is associated with both arterial and ventricular stiffness in healthy subjects. Journal of Cardiology. 2013;62(6):361-365. doi:10.1016/j.jjcc.2013.06.004

A9. Şeker T. Epicardial Fat Thickness is Associated with Abnormal LV Geometry in Newly Diagnosed Hypertension. Acta Cardiologica Sinica. 2019;35(1):91. doi:10.6515/ACS.201901_35(1).20180802B

A10. Şeker T, Türkoğlu C, Uçar H, et al. Treatment of totally occluded aortic coarctation using a covered stent. Herz. 2015;40(2):307-310. doi:10.1007/s00059-013-3984-y

A11. Dönmez E, Koç M, Şeker T, İçen YK, Çaylı M. Assessment of non-culprit coronary lesions in STEMI with multivessel disease by control QCA. International Journal of Cardiovascular Imaging. 2016;32(10):1471-1476. doi:10.1007/s10554-016-0943-8

A12. Şeker T, Gür M, Uçar H, et al. Lower serum 25-hydroxyvitamin D is associated with impaired myocardial performance and LV hypertrophy in newly diagnosed hypertension. The Anatolian Journal of Cardiology. 2015;15(9):744-750. doi:10.5152/akd.2014.5637

A13. Baykan AO, Gür M, Acele A, Şeker T, et al. Predictors of successful PCI in chronic total occlusions. Advances in Interventional Cardiology. 2016;12(1):17-24. doi:10.5114/pwki.2016.56945

A14. Gür M, Çaylı M, Uçar H, et al. Paraoxonase-1 activity in subclinical thoracic aortic atherosclerosis. International Journal of Cardiovascular Imaging. 2014;30(5):889-895. doi:10.1007/s10554-014-0407-y

A15. Kuloğlu O, Gür M, Şeker T, et al. Serum 25-OH Vitamin D is associated with arterial stiffness, LV hypertrophy, and inflammation in newly diagnosed hypertension. Journal of Investigative Medicine. 2013;61(6):989-994.

A16. Baykan AO, Gür M, Acele A, Şeker T, et al. Coronary collateral development and arterial stiffness in chronic total occlusions. Scandinavian Cardiovascular Journal. 2015;49(4):228-234. doi:10.3109/14017431.2015.1062130

A17. Ballı M, Taşolar MH, Çetin M, et al. Is atrial fibrillation a risk factor for contrast-induced nephropathy in STEMI? Journal of Cardiology. 2016;67(4):327-330. doi:10.1016/j.jjcc.2015.09.018

A18. Gür M, Türkoğlu C, Taşkın A, et al. PON-1 activity and oxidative stress in primary PCI with and without no-reflow in anterior STEMI. Atherosclerosis. 2014;234(2):415-420. doi:10.1016/j.atherosclerosis.2014.03.005

A19. Uçar H, Gür M, Kıvrak A, et al. High-sensitivity cardiac troponin T in newly diagnosed hypertensives with different LV geometry. Blood Pressure. 2014;23(4):240-247. doi:10.3109/08037051.2013.840429

A20. Börekçi A, Gür M, Türkoğlu C, et al. Oxidative stress and spontaneous reperfusion in STEMI. Clinical and Applied Thrombosis/Hemostasis. 2015;22(2):171-177. doi:10.1177/1076029614546329

A21. Uçar H, Gür M, Yıldız Koyunsever N, et al. Increased aortic stiffness predicts CIN after PCI in stable CAD. Angiology. 2014;65(9):806-811. doi:10.1177/0003319713504126

A22. Uçar H, Gür M, Gözükara MY, et al. Gamma-glutamyl transferase is associated with oxidative stress rather than SYNTAX score. Scandinavian Journal of Clinical and Laboratory Investigation. 2015;75(1):7-12. doi:10.3109/00365513.2014.954141

A23. Gür M, Uçar H, Kuloğlu O, et al. eGFR is associated with arterial stiffness and NT-proBNP in newly diagnosed hypertension. Clinical and Experimental Hypertension. 2014;36(6):374-379. doi:10.3109/10641963.2013.827703

A24. Kaypaklı O, Gür M, Gözükara MY, et al. hs-TnT, LV hypertrophy, and myocardial performance index. Herz. 2015;40(7):1004-1010. doi:10.1007/s00059-015-4322-3

A25. Kiraz K, Gökdeniz T, Kalaycıoğlu E, et al. Epicardial fat thickness and COPD severity. European Review for Medical and Pharmacological Sciences. 2016;20(21):4508-4515.

A26. Elbasan Z, Gür M, Şahin DY, et al. NT-proBNP and abnormal LV geometry in untreated hypertension. Clinical and Experimental Hypertension. 2013;36(3):153-158. doi:10.3109/10641963.2013.804538

A27. Baykan AO, Yüksel Kalkan G, Gür M, et al. Coronary flow velocity reserve in ascending aorta aneurysm. Echocardiography. 2015;32(6):975-982. doi:10.1111/echo.12782

A28. Çaylı M, Şahin DY, Elbasan Z, et al. Modified flower petal technique for Medina 0,0,1 / 0,1,0 lesions. EuroIntervention. 2015;11(8):772-779. doi:10.4244/EIJV11I7A154

A29. Yüksel Kalkan G, Gür M, Baykan AO, et al. Serum bilirubin and aortic intima-media thickness in asymptomatic patients. Angiology. 2014;65(4):308-312. doi:10.1177/0003319713507627

A30. Çaylı M, Gür M, Elbasan Z, et al. hs-cTnT predicts nondipper hypertension in newly diagnosed hypertensives. Journal of Clinical Hypertension. 2013;15(10):731-736. doi:10.1111/jch.12176

A31. Elbasan Z, Şahin DY, Gür M, et al. Serum uric acid and slow coronary flow in cardiac syndrome X. Herz. 2013;38(5):544-548. doi:10.1007/s00059-012-3735-5

A32. Şahin DY, Gür M, Elbasan Z, et al. SYNTAX score predicts angiographic no-reflow in primary PCI for STEMI. Coronary Artery Disease. 2013;24(2):148-153. doi:10.1097/MCA.0b013e32835c4719

A33. Gözükara MY, Börekçi A, Gür M, et al. GGT activity is associated with both PON1 activity and aortic stiffness in hypertension. Journal of Clinical Laboratory Analysis. 2015;29(5):390-396. doi:10.1002/jcla.21785

A34. Şahin DY, Gür M, Elbasan Z, et al. NT-proBNP predicts impaired myocardial function in newly diagnosed hypertensives with preserved EF. Clinical and Experimental Hypertension. 2014;36(5):289-294. doi:10.3109/10641963.2013.810234

A35. Börekçi A, Gür M, Türkoğlu C, et al. Oxidative stress and PON-1 predict CIN in STEMI undergoing primary PCI. Angiology. 2015;66(4):339-345. doi:10.1177/0003319714533588

A36. Baykan AO, Yüksel Kalkan G, Şahin DY, et al. Coronary flow reserve in donor artery and MPI after CTO recanalization. Journal of Invasive Cardiology. 2015;27(6):75-81.

A37. Börekçi A, Gür M, Şeker T, et al. Coronary collateral circulation in CTO: relation with risk markers and SYNTAX. Perfusion. 2015;30(6):457-464. doi:10.1177/0267659114558287

A38. Börekçi A, Gür M, Türkoğlu C, et al. Neutrophil-to-lymphocyte ratio predicts LV remodeling after primary PCI for STEMI. Korean Circulation Journal. 2016;46(1):15-22. doi:10.4070/kcj.2016.46.1.15

A39. Yüksel Kalkan G, Gür M, Eksi Haydardedeoğlu F, et al. Association between aortic distensibility and coronary flow reserve in newly diagnosed diabetes. Echocardiography. 2015;32(2):205-212. doi:10.1111/echo.12631

A40. Akyol S, Çörtük M, Baykan AO, et al. Mean platelet volume and OSA severity. Clinics (Sao Paulo). 2015;70(7):481-485. doi:10.6061/clinics/2015(07)04

A41. Gür M, Elbasan Z, Şahin DY, et al. DNA damage and oxidative status in dipper vs non-dipper hypertension. Hypertension Research. 2013;36(2):166-171. doi:10.1038/hr.2012.156

A42. Akyol S, Çörtük M, Baykan AO, et al. Biventricular myocardial performance declines proportional to OSA severity. Texas Heart Institute Journal. 2016;43(2):119-125. doi:10.14503/THIJ-14-4868

A43. Şahin DY, Gür M, Elbasan Z, et al. Myocardial Performance Index vs SYNTAX in stable CAD. Echocardiography. 2013;30(4):385-391. doi:10.1111/echo.12077

A44. Çaylı M, Gür M, Elbasan Z, et al. Modified Flower Petal Technique. JACC: Cardiovascular Interventions. 2013;6(5):516-522. doi:10.1016/j.jcin.2012.12.130

A45. Uçar H, Gür M, Yıldız Koyunsever N, et al. Mean platelet volume is independently associated with renal dysfunction in stable CAD. Platelets. 2014;25(4):274-278. doi:10.3109/09537104.2013.805406

A46. Kuloğlu O, Gür M, Şeker T, et al. Serum 25-OH Vitamin D and aortic distensibility/LV hypertrophy in new-onset T2DM. Diabetes & Vascular Disease Research. 2013;10(6):546-549. doi:10.1177/1479164113491125

A47. Çaylı M, Şeker T, Gür M, et al. Jailed Semi-Inflated Balloon Technique: a novel modified provisional bifurcation strategy. Journal of Interventional Cardiology. 2015;28(5):420-429. doi:10.1111/joic.12225

A48. Yüksel Kalkan G, Gür M, Yıldız Koyunsever N, et al. Serum 25-OH Vitamin D and aortic intima-media thickness without clinical ASCVD. Journal of Clinical Laboratory Analysis. 2015;29(4):305-311. doi:10.1002/jcla.21770

A49. Börekçi A, Gür M, Özaltun B, et al. Epicardial fat thickness in stable CAD: relation with hs-cTnT and NT-proBNP. Coronary Artery Disease. 2014;25(8):685-690. doi:10.1097/MCA.0000000000000140

A50. Baykan AO, Gür M, Acele A, Şeker T, et al. Systemic and pulmonary artery stiffness predict ventricular recovery after ASD closure. Congenital Heart Disease. 2016;11(2):144-154. doi:10.1111/chd.12302

A51. Çaylı M, Gür M, Yüksel Kalkan G, et al. GGT activity: relation with thoracic aortic IMT and inflammation. Herz. 2014;39(6):761-766. doi:10.1007/s00059-013-3921-0

A52. Dönmez E, Şeker T, İçen YK, Elbasan Z, Gür M, Çaylı M. Incidental Asymptomatic Accessory Mitral Valve. Acta Médica Portuguesa. 2014;27(6):779-782.

A53. Türkoğlu C, Genç Ö, Şeker T, Kurt İH. Predictive Value of Selvester QRS Score for CAD Severity in STEMI. Cor et Vasa. 2021. (In press at the time noted)

A54. Quisi A, Almadhoun H, Alıcı G, Genç Ö, Şeker T, Kurt İH. Serum Rheumatoid Factor and SYNTAX Score I in MI. Archives of the Turkish Society of Cardiology. 2021. (In press)

A55. Türkoğlu C, Harbalıoğlu H, Şeker T, Baykan AO, Uysal OK. D-dimers are associated with CAD severity (SYNTAX/SYNTAX II) in STEMI. Revista Portuguesa de Cardiologia (English Edition). 2020;39(12):687-693. doi:10.1016/j.repc.2020.08.006

nternational Conference Presentations & Proceedings (B)

B1. Şeker T. Late PCI and CABG for secondary intervention are associated with decreased MACE in multivessel disease after primary PCI. World Heart Rhythm Conference; 2018. Abstract. doi:10.4172/2329-9517-C4-011

B2. Harbalıoğlu H, Şeker T, Çaylı M, Gür M, Şahin DY, Elbasan Z. Simple vs complex stenting strategy in coronary true bifurcation lesions in AMI. EuroPCR Congress; 2016. Abstract.

Book Chapters / Translations (C)

C1. Şeker T. Coronary Artery Bypass Graft Patients — Interventional Approach. In: Advanced Tips in Interventional Cardiology. Çukurova Nobel Medical Publishing; 2014. (Book Translation)

C2. Şeker T. Subclavian Artery Interventions. In: Advanced Tips in Interventional Cardiology. Çukurova Nobel Medical Publishing; 2014. (Book Translation)

C3. Şeker T. Percutaneous Treatment of Congenital Cardiac Anomalies. In: Advanced Tips in Interventional Cardiology. Çukurova Nobel Medical Publishing; 2014. (Book Translation)

National Peer-Reviewed Journal Articles (D)

D1. Şeker T, Türkoğlu C, Akkuş O, Gür M. Visible thrombus material during aspiration predicts no-reflow and in-hospital mortality in anterior STEMI undergoing primary PCI. Archives of the Turkish Society of Cardiology. 2019;47(2):95-102.

D2. Uçar H, Gür M, Şeker T, et al. Impaired kidney function associated with SYNTAX score in stable CAD. Archives of the Turkish Society of Cardiology. 2014;42(7):621-628.

D3. Baykan AO, Gür M, Yüksel Kalkan G, Şeker T, et al. Myocardial performance and aortic elasticity in ascending aortic aneurysm. Archives of the Turkish Society of Cardiology. 2016;44(2):114-122.

D4. Börekçi A, Gür M, Şeker T, et al. Epicardial fat thickness associated with LV performance in newly diagnosed hypertension. Archives of the Turkish Society of Cardiology. 2015;43(8):705-713.

D5. Yüksel Kalkan G, Gür M, Elbasan Z, Şeker T, et al. LV geometry affects coronary flow reserve in diabetes. Archives of the Turkish Society of Cardiology. 2015;43(1):49-57.

D6. Uçar H, Gür M, Börekçi A, Şeker T, et al. Left ventricular geometry and extent of CAD in hypertensive CAD patients. The Anatolian Journal of Cardiology. 2014;15(10):789-794.

D7. Uçar H, Gür M, Gözükara MY, Şeker T, et al. Mean platelet volume and morning BP surge in newly diagnosed HT. The Anatolian Journal of Cardiology. 2015;15(2):107-112.

D8. Elbasan Z, Şahin DY, Gür M, Şeker T, et al. Serum uric acid and CAD severity in stable CAD. Turkish Interventional Cardiology Journal. 2012;16(2):64-70.

D9. Yıldız Koyunsever N, Şahin DY, Şeker T, et al. Stent dimensions used in PCI in Çukurova region. Turkish Interventional Cardiology Journal. 2012;16(2):41-46.

D10. Çağlıyan ÇE, Türkmen S, Şeker T, et al. Diabetic cardiomyopathy signs in hypertensive patients with early hyperglycemia. Turkish Interventional Cardiology Journal. 2012;16(1):20-25.

D11. Şeker T, Baykan AO, Gür M, et al. Spontaneous coronary artery dissection causing STEMI. Turkiye Klinikleri Journal of Case Reports. 2016;24(2):118-122.

D12. Şeker T, Baykan AO, Börekçi A, Gür M, et al. Successful thrombolysis in Takayasu arteritis with massive thrombus. Archives of the Turkish Society of Cardiology. 2014;42(8):763-766.

D13. Baykan AO, Gür M, Acele A, Şeker T, et al. Scorpion sting-induced acute inferior STEMI. Archives of the Turkish Society of Cardiology. 2015;44(1):82-86.

National Congress Abstracts (E)

E1. Şeker T. Peripheral Artery Disease. Vascular & Molecular Cardiology Congress; 2018.

E2. Şeker T. High Selvester QRS score predicts LV remodeling in STEMI. Cardiovascular Academy Congress; 2018.

E3. Şeker T. Relationship between hs-CRP and ischemia-modified albumin in diabetes. Vascular & Molecular Cardiology Congress; 2018.

E4–E9. Şeker T. Various successful interventional cardiology cases presented. National Interventional Cardiology Congress; 2014–2016.

E10. Şahin DY, Gür M, Elbasan Z, Kuloğlu O, Şeker T, et al. SYNTAX predicts no-reflow in STEMI. Turkish Cardiology Congress; 2013.

E11-E12. Şeker T, Dönmez E, et al. BNP levels predict prognosis after primary PCI in STEMI. Turkish Cardiology Congress; 2010.